Gary Neil Cramer offers Preventest from Syncier BioTech

PREVENTEST™ - The first Comprehensive Cancer Risk Assessment test designed to


determine your patient’s risk of developing up to eight types of cancer.

This non-invasive test helps physicians determine the level


of risk for some of the most common solid tumor cancers including


Breast, Ovarian, Endometrial,


Pancreas, Prostate, Skin, Stomach and Colorectal Cancers.


PREVENTEST™ can help identify the patient’s risk level of developing one


or more of these eight


prevalent cancers in early stage detection.

For more information please give Gary Cramer a call at 360-909-0723